These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 38799441)
1. Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita. Gross N; Marketon J; Mousavi S; Kalies K; Ludwig RJ; Bieber K Front Immunol; 2024; 15():1343299. PubMed ID: 38799441 [TBL] [Abstract][Full Text] [Related]
2. Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita. Kovacs B; Tillmann J; Freund LC; Nimmerjahn F; Sadik CD; Bieber K; Ludwig RJ; Karsten CM; Köhl J Front Immunol; 2019; 10():3012. PubMed ID: 31993051 [TBL] [Abstract][Full Text] [Related]
3. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita. Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985 [TBL] [Abstract][Full Text] [Related]
4. Granzyme B inhibition reduces autoantibody-induced dermal-epidermal separation in an ex vivo model of epidermolysis bullosa acquisita. Emtenani S; Lebhar H; Marquis CP; Ludwig RJ; Schmidt E Exp Dermatol; 2024 Sep; 33(9):e15172. PubMed ID: 39219105 [TBL] [Abstract][Full Text] [Related]
10. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734 [TBL] [Abstract][Full Text] [Related]
11. B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita. Iwata H; Bieber K; Tiburzy B; Chrobok N; Kalies K; Shimizu A; Leineweber S; Ishiko A; Vorobyev A; Zillikens D; Köhl J; Westermann J; Seeger K; Manz R; Ludwig RJ J Immunol; 2013 Sep; 191(6):2978-88. PubMed ID: 23960233 [TBL] [Abstract][Full Text] [Related]
12. Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita. Ishii N; Recke A; Mihai S; Hirose M; Hashimoto T; Zillikens D; Ludwig RJ J Pathol; 2011 Jun; 224(2):234-44. PubMed ID: 21381035 [TBL] [Abstract][Full Text] [Related]
13. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. Woodley DT; Ram R; Doostan A; Bandyopadhyay P; Huang Y; Remington J; Hou Y; Keene DR; Liu Z; Chen M J Invest Dermatol; 2006 Jun; 126(6):1323-30. PubMed ID: 16543893 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita. Haeger SC; Kridin K; Pieper M; Griewahn L; Nimmerjahn F; Zillikens D; König P; Ludwig RJ; Hundt JE Front Immunol; 2022; 13():938306. PubMed ID: 36311755 [TBL] [Abstract][Full Text] [Related]
15. PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita. Koga H; Recke A; Vidarsson G; Pas HH; Jonkman MF; Hashimoto T; Kasprick A; Ghorbanalipoor S; Tenor H; Zillikens D; Ludwig RJ J Invest Dermatol; 2016 Nov; 136(11):2211-2220. PubMed ID: 27388992 [TBL] [Abstract][Full Text] [Related]
16. The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita. Sadeghi H; Gupta Y; Möller S; Samavedam UK; Behnen M; Kasprick A; Bieber K; Müller S; Kalies K; de Castro Marques A; Recke A; Schmidt E; Zillikens D; Laskay T; Mariani J; Ibrahim SM; Ludwig RJ J Pathol; 2015 Sep; 237(1):111-22. PubMed ID: 25953430 [TBL] [Abstract][Full Text] [Related]
17. Preventive but Not Therapeutic Topical Application of Local Anesthetics Can Inhibit Experimental Epidermolysis Bullosa Acquisita in Mice. Wen L; Dong X; Li Q; Schramm G; Zhang B; Zillikens D; Ludwig RJ; Petersen F; Yu X Front Immunol; 2021; 12():750160. PubMed ID: 34712239 [TBL] [Abstract][Full Text] [Related]
18. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita. Bieber K; Witte M; Sun S; Hundt JE; Kalies K; Dräger S; Kasprick A; Twelkmeyer T; Manz RA; König P; Köhl J; Zillikens D; Ludwig RJ Sci Rep; 2016 Dec; 6():38357. PubMed ID: 27917914 [TBL] [Abstract][Full Text] [Related]
19. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies. Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468 [TBL] [Abstract][Full Text] [Related]
20. Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice. Hammers CM; Bieber K; Kalies K; Banczyk D; Ellebrecht CT; Ibrahim SM; Zillikens D; Ludwig RJ; Westermann J J Immunol; 2011 Nov; 187(10):5043-50. PubMed ID: 21967893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]